Cinsulin (Cinnamon Extract)

Cinsulin is a patented water-soluble cinnamon extract (Cinnamomum cassia) standardized for Type-A polymeric polyphenols, which enhance insulin receptor signaling by activating insulin receptor kinase and inhibiting protein tyrosine phosphatase. Its primary mechanism centers on improving cellular glucose uptake and insulin sensitivity without the coumarin-related liver toxicity concerns associated with whole cinnamon powder.

Origin & History

Cinsulin (CinSulin®) is a branded, water-soluble cinnamon extract derived from the bark of Cinnamomum cassia or related Cinnamomum species. It is produced via a patented 100% water-based extraction process without chemical solvents, yielding a clear yellow liquid containing bioactive compounds including cinnamaldehyde, cinnamic acid, cinnamyl alcohol, and eugenol.

Historical & Cultural Context

Cinnamon bark (Cinnamomum species) has been used in traditional Chinese medicine for millennia to lower blood sugar, reduce blood fat, and protect liver function. These traditional applications are referenced in modern extraction patents for pharmaceutical use.

Health Benefits

• Protein aggregation inhibition: In vitro studies show cinnamon water extracts inhibit tau protein aggregation associated with Alzheimer's disease at concentrations up to 0.22 mg/mL (preliminary evidence)
• Anticancer properties: Water extracts demonstrated cancer cell inhibition at concentrations up to 1.28 mg/mL in laboratory studies, with synergistic effects at 80 μg/mL (preliminary evidence)
• Antioxidant activity: Contains polyphenols and phenolic compounds that provide antioxidant effects through total phenol content (preliminary evidence)
• Traditional blood sugar support: Referenced in patents for pharmaceutical applications based on traditional Chinese medicine use, though no clinical trials available for Cinsulin specifically
• Liver protection: Traditional use documented in Chinese medicine for protecting liver function, though no modern clinical evidence for this branded extract

How It Works

Cinsulin's Type-A polyphenol polymers activate insulin receptor substrate-1 (IRS-1) phosphorylation and stimulate GLUT4 transporter translocation to cell membranes, increasing glucose uptake in skeletal muscle and adipose tissue. These compounds also inhibit protein tyrosine phosphatase-1B (PTP1B), an enzyme that normally dephosphorylates and inactivates the insulin receptor, thereby prolonging insulin signaling. Additionally, the polyphenols activate AMPK (AMP-activated protein kinase), further promoting glucose metabolism independent of direct insulin receptor binding.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses specifically on Cinsulin (CinSulin®) were identified. The available evidence consists entirely of in vitro studies on general cinnamon water extracts showing effects on tau protein aggregation (C. zeylanicum) and cancer cell inhibition (C. cassia), not the branded ingredient itself.

Clinical Summary

A randomized, double-blind, placebo-controlled trial in 22 adults with type 2 diabetes found that 500 mg of Cinsulin daily for 12 weeks reduced fasting blood glucose by approximately 8–10% compared to placebo. A larger 2010 study (n=109) published in the Journal of the International Society of Sports Nutrition reported significant reductions in fasting glucose and modest improvements in postprandial glucose response with 500 mg daily dosing. Evidence is considered promising but preliminary; most trials are small, short-duration, and use Cinsulin in conjunction with standard care, limiting standalone conclusions. Head-to-head comparisons with metformin or other hypoglycemic agents are lacking, and long-term safety data beyond 6 months remain insufficient.

Nutritional Profile

Cinsulin is a standardized water-soluble cinnamon extract (typically derived from Cinnamomum burmannii or Cinnamomum cassia), concentrated to provide the bioactive polyphenol fraction while reducing lipid-soluble compounds. Key bioactive compounds include: • Type-A procyanidins (doubly-linked proanthocyanidins): primary active constituents, estimated at 50–100 mg per typical 500 mg extract dose, responsible for insulin-sensitizing activity • Cinnamaldehyde: present in reduced amounts compared to whole cinnamon bark (~1–5% of extract vs. ~1–4% in raw bark) due to the water-extraction process removing much of the volatile oil fraction • Polyphenols (total): approximately 100–200 mg gallic acid equivalents per 500 mg standardized extract, including catechins, epicatechins, and phenolic acids • Chromium: trace amounts (~0.5–2 µg per serving), naturally occurring in cinnamon but not a significant dietary source • Coumarin: significantly reduced in water-extracted forms compared to whole cassia cinnamon powder (typically <0.1 mg per dose vs. 2–5 mg in equivalent whole cinnamon), an important safety advantage • Minerals (trace): manganese (~0.1–0.3 mg per 500 mg dose), calcium, and iron in negligible quantities • Fiber and macronutrients: essentially absent in concentrated extract form; caloric contribution is negligible (<2 kcal per dose) • Eugenol: minor constituent (~0.01–0.05%), contributing mild antioxidant activity • Cinnamic acid and cinnamate derivatives: present at low concentrations (~1–3% of extract), contributing to anti-inflammatory and metabolic effects. Bioavailability notes: The water-soluble Type-A procyanidins demonstrate moderate oral bioavailability; they are partially absorbed in the small intestine and further metabolized by gut microbiota into smaller phenolic acids. The removal of lipid-soluble fractions during manufacturing is designed to enhance the proportion of water-soluble polyphenolic actives. Standard dosing in clinical studies ranges from 250–500 mg of extract per day (often standardized to a specific polyphenol content, e.g., Cinnulin PF® is standardized to ≥3% Type-A polymers). Peak plasma polyphenol metabolites appear within 1–3 hours post-ingestion.

Preparation & Dosage

No clinically studied dosage ranges for Cinsulin have been established due to lack of human trials. Commercial CinSulin® is provided at 500 mg per serving via water extraction, though standardization details are not available. In vitro studies used concentrations ranging from 80 μg/mL to 1.28 mg/mL of general cinnamon water extracts. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Chromium picolinate, Alpha-lipoic acid, Gymnema sylvestre, Bitter melon extract, Berberine

Safety & Interactions

Cinsulin is generally well-tolerated at doses of 500–1500 mg/day, with its water-soluble formulation specifically designed to minimize coumarin content, reducing hepatotoxicity risk compared to whole Cassia cinnamon. Concurrent use with insulin, metformin, sulfonylureas, or other hypoglycemic agents may cause additive blood glucose lowering and increase the risk of hypoglycemia, requiring blood sugar monitoring. Individuals on warfarin should exercise caution, as cinnamon-derived compounds may modestly potentiate anticoagulant effects by inhibiting platelet aggregation. Cinsulin is not recommended during pregnancy or lactation due to insufficient safety data, and individuals with liver disease should consult a physician before use.